Momenta To Pay $35M To Exit Blood Clot Drug Antitrust Suit
Momenta has agreed to pay $35 million to exit a class action brought by a group of drug buyers accusing the company and Sandoz of conspiring to monopolize the blood clot...To view the full article, register now.
Already a subscriber? Click here to view full article